Across TCGA pan-cancer cohorts, HNRNPCP6 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of HNRNPCP6’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where HNRNPCP6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HNRNPCP6 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.
BRCA, LUAD, and LUSC are the cancer types where HNRNPCP6 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPCP6 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.